Lab Updates

Lab Update 18 – Laboratory Monitoring of Patients with COVID-19

Lab Updates
Lab Update 18 – Laboratory Monitoring of Patients with COVID-19
Read Document

June 2020
Dr Marita du Plessis – Chemical Pathologist
Ampath | ampath.co.za

The Laboratory’s Role in COVID-19 Care

Laboratory testing plays a vital role in:

  • Diagnosing COVID-19 using real-time reverse transcription PCR (rRT-PCR)
  • Assessing disease severity
  • Monitoring disease progression and guiding treatment decisions

Tests should be performed on hospital admission in patients with:

  • Suspected severe COVID-19
  • Significant comorbidities

Key Laboratory Tests, Expected Abnormalities, and Clinical Significance

✅ Full Blood Count (FBC)

  • Abnormalities:
    • Increased WBC count (rare)
    • Increased neutrophils
    • Decreased lymphocytes
    • Normal or reduced platelets (thrombocytopenia warrants further investigation)
  • Clinical significance:
    • May indicate bacterial superinfection, T-cell destruction, acute inflammatory response
  • Odds ratio for in-hospital death: 6.60 (WBC >10 x 10⁹/L)

✅ D-dimer

  • Abnormality: Increased
  • Clinical significance: Activation of coagulation and fibrinolysis
  • Odds ratio: 20.04 (if D-dimer >1 mg/L)

✅ Prothrombin Time (PT)

  • Abnormality: Increased
  • Clinical significance: Coagulation activation
  • Odds ratio: 4.62 (if PT ≥16 seconds)

✅ Arterial Blood Gas

  • Abnormalities:
    • Decreased pO₂ and O₂ saturation
    • Hypercarbia
    • Acidosis
  • Clinical significance: Key in managing critically ill patients

✅ C-reactive Protein (CRP)

  • Abnormality: Increased
  • Clinical significance: Suggests severe viral infection, viraemia, or sepsis

✅ Procalcitonin (PCT)

  • Abnormality: Increased
  • Clinical significance: Indicates bacterial superinfection
  • Odds ratio: 13.75 (if PCT ≥0.5 ng/mL)

✅ Ferritin

  • Abnormality: Increased
  • Clinical significance:
    • Severe inflammation
    • Thrombotic microangiopathy
    • Secondary haemophagocytic lymphohistiocytosis (sHLH)
  • Odds ratio: 9.10 (if ferritin >300 ng/mL)

✅ Urea & Creatinine

  • Abnormality: Increased
  • Clinical significance: Kidney injury
  • Odds ratio for creatinine: 4.39 (if >133 µmol/L)

✅ Glucose

  • Abnormality: Variable
  • Clinical significance: Uncontrolled hyperglycaemia worsens prognosis in both diabetic and non-diabetic patients

✅ Albumin

  • Abnormality: Decreased
  • Clinical significance: Suggests impaired liver function

✅ Total Bilirubin, ALT, AST

  • Abnormalities: Increased
  • Clinical significance: Liver injury and/or general organ damage

✅ Lactate Dehydrogenase (LDH)

  • Abnormality: Increased
  • Clinical significance:
    • Liver or pulmonary injury
    • Widespread tissue damage

✅ Creatine Kinase (CK)

  • Abnormality: Increased
  • Clinical significance: Muscle injury

✅ High-Sensitivity Troponins (hsTroponin or hsTn)

  • Abnormality: Increased
  • Clinical significance: Cardiac injury
  • Odds ratio: 80.07 (if hsTn >99th percentile)

Additional Inflammatory Marker: Interleukin-6 (IL-6)

  • IL-6 is recommended as a marker for cytokine storm syndrome, often seen in patients with severe COVID-19.

Markers Predictive of Disease Severity and Mortality

The following lab findings are associated with worse outcomes:

  • High neutrophil-to-lymphocyte ratio (>1.4)
  • Persistent low counts of:
    • CD4
    • CD8
    • CD19+ B cells
    • NK cells (CD16+CD56+)
  • Increased levels of:
    • D-dimer
    • Creatinine
    • LDH (>245 U/L)
    • CK
    • Ferritin
    • CRP
    • IL-6
    • Procalcitonin
    • hsTroponin
    • Glucose (hyperglycaemia)

Top Predictors of In-Hospital Death

According to Zhou et al. (2020), the strongest independent risk factors for death were:

  • Increased age
  • D-dimer >1 mg/L
  • High SOFA score (Sequential Organ Failure Assessment)

These markers help identify high-risk patients early.

References

  1. International Federation of Clinical Chemistry (IFCC), 2020
  2. BMJ Best Practice, 2019
  3. Zhou F. et al., Lancet, 395: 1054–62
  4. Favaloro & Lippi, 2020 – Thieme Medical Publishers
  5. Liu Y. et al., Science China Life Science, 2020
  6. He R. et al., Journal of Clinical Virology, 2020
  7. Velavan TP & Meyer CG, Int. J. Infect. Dis., 2020
  8. Xu B. et al., Chin Journal of Infection, 2020

📌 Please contact your local Ampath pathologist for more information or patient-specific guidance.